Researcher.Life Logo

Journal of Market Access & Health Policy : Impact Factor & More

eISSN: 2001-6689
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Market Access & Health Policy

Journal of Market Access & Health Policy Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher Taylor & Francis Group
Language English
Article Processing ChargesGBP 1190
Publication Time14
Editorial Review ProcessDouble blind peer review
General Details
LanguageEnglish
Society/Institute/SponsorMarket Access Society
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 14
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble blind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in Journal of Market Access & Health Policy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Market Access & Health Policy

An Empirical Comparison of Statistical Methods for Estimating Treatment Effects on EQ-5D in Randomized Clinical Trials.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Official Digital Health Technology Assessment Guidelines: An International Comparative Review and Analysis.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
A Cost-Utility Analysis of LISTEN: Low-Intensity Mental Health Support via Telehealth-Enabled Network for Diabetes Distress.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Assessing the agreement between self- and proxy-reported responses for measuring health-related quality of life in people with dementia using the Alzheimer's Disease Five Dimensions instrument.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
How much change is meaningful in global impression anchors? Evidence from five rare diseases.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Adoption of Managed Entry Agreements for Advanced Therapy Medicinal Products: Semi-Structured Interviews with HTA bodies and Decision Makers in England, the Netherlands, and Spain.
  • 8 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
An Empirical Comparison of Statistical Methods for Estimating Treatment Effects on EQ-5D in Randomized Clinical Trials.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Official Digital Health Technology Assessment Guidelines: An International Comparative Review and Analysis.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
A Cost-Utility Analysis of LISTEN: Low-Intensity Mental Health Support via Telehealth-Enabled Network for Diabetes Distress.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Assessing the agreement between self- and proxy-reported responses for measuring health-related quality of life in people with dementia using the Alzheimer's Disease Five Dimensions instrument.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
How much change is meaningful in global impression anchors? Evidence from five rare diseases.
  • 15 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Adoption of Managed Entry Agreements for Advanced Therapy Medicinal Products: Semi-Structured Interviews with HTA bodies and Decision Makers in England, the Netherlands, and Spain.
  • 8 May 2026
  • Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

FAQs on Journal of Market Access & Health Policy